Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination

BACKGROUND: Bisdemethoxycurcumin (BDMC), a stable bioactive ingredient in curcuminoids, is associated with various antitumor functions, such as proliferation inhibition, metastasis suppression and apoptosis induction, in many cancer types. However, the mechanism of BDMC in hepatocellular carcinoma (...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Drug Des Devel Ther
Huvudupphovsmän: Qiu, Chengjiang, Liu, Kairui, Zhang, Sheng, Gao, Simin, Chen, Weirun, Li, Dateng, Huang, Youxing
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7062405/
https://ncbi.nlm.nih.gov/pubmed/32184568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S231814
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk